Foresite Capital Management V, LLC, Ten Percent Owner at Pardes Biosciences, holds 1.39M shares in Theseus Pharmaceuticals (Ticker: THRX), holds 13.58M shares in Pardes Biosciences (Ticker: PRDS). Most recently, Foresite Capital Management V, LLC Bought ― shares of Theseus Pharmaceuticals on Jul 19, 2023 for an estimated value of 2.08M.